Aug 2026· Academic Journal of International University of Erbil· 0 citations· 42 references
TL;DR
Recent progress in AI-driven approaches for AD detection is discussed and the importance of interdisciplinary strategies to facilitate earlier diagnosis, improve patient outcomes, and support more effective management of Alzheimer's disease is underscored.
Abstract
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and a leading cause of dementia worldwide. Conventional diagnostic methods, including cerebrospinal fluid analysis and clinical evaluation, are invasive and typically effective only at later stages, despite the importance of early detection for therapeutic success. Advances in neuroimaging, particularly magnetic resonance imaging (MRI), coupled with machine learning (ML) and deep learning (DL), have enabled non-invasive identification of structural and functional brain alterations characteristic of AD. Convolutional neural networks (CNNs) and long short-term memory (LSTM) models are particularly effective for processing large-scale volumetric and temporal data. Incorporating genetic and clinical biomarkers alongside imaging data further enhances diagnostic performance. Nonetheless, significant challenges remain, including limited datasets, heterogeneous sources of information, algorithm interpretability, and ethical considerations. Emerging solutions such as federated learning, standardized preprocessing pipelines, and explainable AI (XAI) frameworks aim to address these barriers and improve the reliability of computational models in clinical settings. This review discusses recent progress in AI-driven approaches for AD detection and underscores the importance of interdisciplinary strategies to facilitate earlier diagnosis, improve patient outcomes, and support more effective management of Alzheimer’s disease.
An advanced DL-powered framework for the early prediction of AD using MRI data demonstrates high accuracy, robustness, and interpretability, supporting its potential for reliable early AD diagnosis in clinical settings.
K. V. S. V. Trinadh Reddy, Gundeboyina Srinivasalu, T. V. Rao et al.· Archives of Medical Research· 0 citations
Alzheimer’s Disease (AD) is a progressive neurological disorder that impairs cognitive functions, severely affecting patients’ quality of life. Thus, early and accurate diagnosis is essential to provide a chance for treatment. This paper proposes two deep learning (DL) models to enable automated diagnosis of medical im...
Sarah Oraby, Ahmed A. Emran, Basel El-Saghir et al.· Scientific Reports· 0 citations
A key finding documented in this work is the difficulty of classifying the transition from Non-Demented to Very Mild Demented stages, observed consistently across all ten CNN architectures.
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, where traditional diagnostic methods are constrained by limited sensitivity and restricted clinical utility. This review synthesizes recent applications of artificial intelligence (AI) in AD diagnostics, focusing on machine learning (ML) and deep lea...
En-Qi Liu, Mei-Jia Cheng, Ye-Tao Ju et al.· Frontiers in Neurology· 0 citations
Abstract AI-assisted early diagnosis of Alzheimer’s disease (AD) has substantial clinical value, and diffusion tensor imaging (DTI), which captures white matter microstructural alterations, has considerable potential across the AD continuum. However, major barriers to clinical translation remain. This review systematic...
Heng-Fei Jia, Shui-Cai Wu, Xin-Nan Xue et al.· Reviews in the Neurosciences· 0 citations
This review synthesizes recent advances in AI-based AD diagnosis, tracing the evolution from traditional ML to DL and LLMs and particular emphasis is placed on the emerging role of LLMs in extracting disease-related information from speech and clinical narratives, integrating heterogeneous biomedical data sources, and...
Xia-Yao Guo, Yan-Qi Sun, Yang Chen et al.· Biosensors· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.